Vaxcyte:Vax-31成人三期非劣效性试验(Opus-1)持续招募受试者,关键数据预计2026年第四季度公布

美股速递
Jan 23

Vaxcyte, Inc. 宣布,其针对成人群体开展的Vax-31三期非劣效性临床试验(代号Opus-1)目前正按计划持续推进受试者招募工作。该试验旨在评估疫苗的免疫效果,公司预期将于2026年第四季度获得并公布关键的顶线数据结果。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10